Literature DB >> 8194162

Cellular pharmacology of the partially non-cross-resistant anthracycline annamycin entrapped in liposomes in KB and KB-V1 cells.

R Perez-Soler1, Y H Ling, Y Zou, W Priebe.   

Abstract

The in vitro cytotoxicity, cellular pharmacology, and DNA lesions induced by the lipophilic anthracycline annamycin (Ann) were studied in KB and KB-V1 (multidrug-resistant) cells. Ann was tested in suspension in saline and 10% dimethylsulfoxide (DMSO: final concentration, 0.05%-0.5%) or entrapped in multilamellar liposomes (median size, 1.57 microns). Doxorubicin (Dox) was about twice as cytotoxic as Ann or liposome-entrapped Ann (L-Ann) against KB cells. Both Ann and L-Ann displayed a partial lack of cross-resistance with Dox (resistance indices: > 60 for Dox, 4.7 for Ann, 4.0 for L-Ann). Accumulation of Ann in KB and KB-V1 cells was consistently about 2-3 and 10-20 times higher, respectively, than that of Dox. Cellular retention of Ann in KB and KB-V1 cells was about 2 and 30 times higher, respectively, than that of Dox as a result of the different efflux patterns of the two drugs: Dox was not effluxed from KB cells but was significantly effluxed from KB-V1 cells (66% at 1 h, whereas Ann efflux was similar in both cell lines (about 50% at 1 h). Dox retention in KB-V1 cells was increased by a factor of 2 in the presence of verapamil or cyclosporine A, but Ann retention was not. In addition, accumulation of Dox in KB-V1 cells was enhanced by the metabolic inhibitor deoxyglucose/azide and the membrane carboxylic ionophore monensin, whereas accumulation of Ann was not affected by either agent. All these findings indicate significant differences in the cellular transmembrane transport systems between Dox and Ann and suggest that Ann efflux is not mediated by P-glycoprotein. Liposome entrapment reduced by a factor of 1.3-2.0 the cellular accumulation of Ann without affecting its cytotoxicity. As compared with Dox, both Ann and L-Ann induced 3 times more DNA double- and single-strand breaks in KB cells. In KB-V1 cells, Dox did not induce DNA damage, whereas the extent of DNA breaks induced by both Ann and L-Ann was similar to that induced by Dox in KB cells. Our results indicate (1) that the lack of cross-resistance between Ann and Dox is associated with a markedly enhanced accumulation and retention of Ann in KB-V1 cells and (2) that the type of liposomes used does not significantly affect the cellular effects of Ann.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8194162     DOI: 10.1007/bf00685927

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  33 in total

Review 1.  Multidrug resistance.

Authors:  J A Moscow; K H Cowan
Journal:  J Natl Cancer Inst       Date:  1988-03-02       Impact factor: 13.506

2.  DNA crosslinking by 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin in HT-29 human colon carcinoma cells in vitro.

Authors:  A Begleiter; J B Johnston
Journal:  Biochem Biophys Res Commun       Date:  1985-08-30       Impact factor: 3.575

3.  Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies.

Authors:  A Gabizon; D C Price; J Huberty; R S Bresalier; D Papahadjopoulos
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

4.  Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II.

Authors:  K Wassermann; J Markovits; C Jaxel; G Capranico; K W Kohn; Y Pommier
Journal:  Mol Pharmacol       Date:  1990-07       Impact factor: 4.436

5.  Resistance to N-benzyladriamycin-14-valerate in mouse J774.2 cells: P-glycoprotein expression without reduced N-benzyladriamycin-14-valerate accumulation.

Authors:  L Lothstein; T W Sweatman; M E Dockter; M Israel
Journal:  Cancer Res       Date:  1992-06-15       Impact factor: 12.701

6.  Chemical and biological characterization of 4'-iodo-4'-deoxydoxorubicin.

Authors:  B Barbieri; F C Giuliani; T Bordoni; A M Casazza; C Geroni; O Bellini; A Suarato; B Gioia; S Penco; F Arcamone
Journal:  Cancer Res       Date:  1987-08-01       Impact factor: 12.701

7.  Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.

Authors:  A Gabizon; D Papahadjopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

8.  Liposome-mediated modulation of multidrug resistance in human HL-60 leukemia cells.

Authors:  A Rahman; S R Husain; J Siddiqui; M Verma; M Agresti; M Center; A R Safa; R I Glazer
Journal:  J Natl Cancer Inst       Date:  1992-12-16       Impact factor: 13.506

9.  9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistance.

Authors:  H M Coley; P R Twentyman; P Workman
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

10.  Organ distribution and tumor uptake of annamycin, a new anthracycline derivative with high affinity for lipid membranes, entrapped in multilamellar vesicles.

Authors:  Y Zou; W Priebe; Y H Ling; R Perez-Soler
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

View more
  2 in total

1.  Improving intracellular doxorubicin delivery through nanoliposomes equipped with selective tumor cell membrane permeabilizing short-chain sphingolipids.

Authors:  Lília R Cordeiro Pedrosa; Albert van Hell; Regine Süss; Wim J van Blitterswijk; Ann L B Seynhaeve; Wiggert A van Cappellen; Alexander M M Eggermont; Timo L M ten Hagen; Marcel Verheij; Gerben A Koning
Journal:  Pharm Res       Date:  2013-05-11       Impact factor: 4.200

2.  Pharmacology of liposomal vincristine in mice bearing L1210 ascitic and B16/BL6 solid tumours.

Authors:  L D Mayer; D Masin; R Nayar; N L Boman; M B Bally
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.